The autonomic nervous system and inflammation in chronic kidney disease.

IF 5.6 2区 医学 Q1 TRANSPLANTATION Nephrology Dialysis Transplantation Pub Date : 2025-08-01 DOI:10.1093/ndt/gfaf020
Carmine Zoccali, Francesca Mallamaci, Mehmet Kanbay, Katherine R Tuttle, Peter Kotanko, Raffaele De Caterina, Guido Grassi, Giuseppe Mancia
{"title":"The autonomic nervous system and inflammation in chronic kidney disease.","authors":"Carmine Zoccali, Francesca Mallamaci, Mehmet Kanbay, Katherine R Tuttle, Peter Kotanko, Raffaele De Caterina, Guido Grassi, Giuseppe Mancia","doi":"10.1093/ndt/gfaf020","DOIUrl":null,"url":null,"abstract":"<p><p>The autonomic nervous system plays a crucial role in regulating physiological processes and maintaining homeostasis through its two branches: the sympathetic nervous system and the parasympathetic nervous system. Dysregulation of the autonomic system, characterized by increased sympathetic activity and reduced parasympathetic tone, is a common feature in chronic kidney disease (CKD) and cardiovascular disease. This imbalance contributes to a pro-inflammatory state, exacerbating disease progression and increasing the risk for cardiovascular events. The sympathetic system promotes inflammation by releasing catecholamines, which activate adrenergic receptors on immune cells. The parasympathetic system exerts anti-inflammatory effects via the cholinergic anti-inflammatory pathway mediated by the vagus nerve. Targeting the autonomic system to restore the balance between the sympathetic and the parasympathetic components offers promising approaches to reduce inflammation and improve outcomes in CKD and cardiovascular disease. β-Blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers are pharmacological agents that modulate sympathetic activity and have shown anti-inflammatory effects. Lifestyle interventions, such as a healthy diet, physical exercise, mindfulness, and meditation, enhance parasympathetic activity and improve autonomic function. Vagus nerve stimulation has emerged as a promising therapy, demonstrating significant potential in reducing inflammation and improving clinical outcomes in various conditions, including CKD, myocardial infarction, and stroke. Despite mixed results in heart failure trials, vagal nerve stimulation has consistently improved quality-of-life measures. Understanding the mechanisms underlying autonomic system regulation of inflammation can inform the development of novel therapeutic strategies to restore autonomic balance and improve patient outcomes in CKD and cardiovascular disease.</p>","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":" ","pages":"1470-1482"},"PeriodicalIF":5.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrology Dialysis Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ndt/gfaf020","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

The autonomic nervous system plays a crucial role in regulating physiological processes and maintaining homeostasis through its two branches: the sympathetic nervous system and the parasympathetic nervous system. Dysregulation of the autonomic system, characterized by increased sympathetic activity and reduced parasympathetic tone, is a common feature in chronic kidney disease (CKD) and cardiovascular disease. This imbalance contributes to a pro-inflammatory state, exacerbating disease progression and increasing the risk for cardiovascular events. The sympathetic system promotes inflammation by releasing catecholamines, which activate adrenergic receptors on immune cells. The parasympathetic system exerts anti-inflammatory effects via the cholinergic anti-inflammatory pathway mediated by the vagus nerve. Targeting the autonomic system to restore the balance between the sympathetic and the parasympathetic components offers promising approaches to reduce inflammation and improve outcomes in CKD and cardiovascular disease. β-Blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers are pharmacological agents that modulate sympathetic activity and have shown anti-inflammatory effects. Lifestyle interventions, such as a healthy diet, physical exercise, mindfulness, and meditation, enhance parasympathetic activity and improve autonomic function. Vagus nerve stimulation has emerged as a promising therapy, demonstrating significant potential in reducing inflammation and improving clinical outcomes in various conditions, including CKD, myocardial infarction, and stroke. Despite mixed results in heart failure trials, vagal nerve stimulation has consistently improved quality-of-life measures. Understanding the mechanisms underlying autonomic system regulation of inflammation can inform the development of novel therapeutic strategies to restore autonomic balance and improve patient outcomes in CKD and cardiovascular disease.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性肾脏疾病的自主神经系统与炎症。
自主神经系统通过交感神经系统(SNS)和副交感神经系统(副交感神经系统)在调节生理过程和维持体内平衡中起着至关重要的作用。自主神经系统失调,以交感神经活动增加和副交感神经张力降低为特征,是慢性肾脏疾病(CKD)和心血管疾病的共同特征。这种不平衡导致促炎状态,加剧疾病进展并增加心血管事件的风险。交感神经系统通过释放儿茶酚胺来促进炎症,儿茶酚胺会激活免疫细胞上的肾上腺素能受体。副交感神经系统通过迷走神经介导的胆碱能抗炎途径发挥抗炎作用。靶向自主神经系统来恢复交感神经和副交感神经成分之间的平衡,为减少炎症和改善CKD和心血管疾病的预后提供了有希望的方法。受体阻滞剂、血管紧张素转换酶抑制剂(ACEi)和血管紧张素受体阻滞剂(ARBs)是调节交感神经活动并具有抗炎作用的药物。生活方式干预,如健康饮食、体育锻炼、正念和冥想,可增强副交感神经活动并改善自主神经功能。迷走神经刺激已经成为一种很有前景的治疗方法,在各种疾病(包括CKD、心肌梗死和中风)中显示出显著的减少炎症和改善临床结果的潜力。尽管在心力衰竭试验中结果不一,但迷走神经刺激始终能改善生活质量。了解自主神经系统调节炎症的机制可以为开发新的治疗策略提供信息,以恢复自主神经平衡,改善慢性肾病和心血管疾病患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation 医学-泌尿学与肾脏学
CiteScore
10.10
自引率
4.90%
发文量
1431
审稿时长
1.7 months
期刊介绍: Nephrology Dialysis Transplantation (ndt) is the leading nephrology journal in Europe and renowned worldwide, devoted to original clinical and laboratory research in nephrology, dialysis and transplantation. ndt is an official journal of the [ERA-EDTA](http://www.era-edta.org/) (European Renal Association-European Dialysis and Transplant Association). Published monthly, the journal provides an essential resource for researchers and clinicians throughout the world. All research articles in this journal have undergone peer review. Print ISSN: 0931-0509.
期刊最新文献
Genome-wide donor-recipient non-HLA mismatch and graft loss. Chronic lung diseases and kidney disease: pathophysiology and management. SGLT2 inhibition for patients with ADPKD - closing the evidence gap. Cardiovascular involvement in ANCA-associated vasculitis. Kidney stone biology: insights from genetics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1